All sites C00-96,D32-33,D42-43,D45-47,D76 1433 88.5 1.7 3.3 1.1 5.4
Mouth, pharynx C00-14 24 96.7 2.5 0.8 - -
  Lip C00 3 93.8 - 6.3 - -
  Tongue C02 7 100.0 - - - -
  Mouth, other C03-06 7 100.0 - - - -
  Salivary glands C07-08 3 80.0 20.0 - - -
  Pharynx C01,C09-14 4 100.0 - - - -
Digestive organs C15-26 260 74.8 0.6 11.2 2.6 10.8
  Oesophagus C15 9 95.7 - 2.2 - 2.2
  Stomach C16 26 93.8 - 0.8 0.8 4.7
  Small intestine C17 3 81.3 - 12.5 6.3 -
  Colon C18 93 91.8 - 2.6 0.9 4.7
  Rectum, rectosigmoid C19-20 35 97.1 - 1.1 - 1.7
  Anus C21 3 92.9 - - - 7.1
  Liver C22 15 64.5 3.9 17.1 5.3 9.2
  Gallbladder, bile ducts C23-24 13 39.4 1.5 33.3 1.5 24.2
  Pancreas C25 56 37.0 1.4 30.2 6.0 25.3
  Other digestive organs C26 7 20.6 - 23.5 17.6 38.2
Respiratory organs C30-39 90 75.4 8.0 6.9 1.8 8.0
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 3 100.0 - - - -
  Lung, trachea C33-34 85 74.9 8.5 7.3 1.4 8.0
  Mediastinum, pleura C38 - - - - - -
Bone C40-41 1 83.3 - - - 16.7
Melanoma of the skin C43 62 100.0 - - - -
Skin, non-melanoma C44 73 100.0 - - - -
Mesothelioma C45 3 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 9 95.7 - 2.1 - 2.1
Breast C50 463 99.5 0.1 0.1 0.0 0.2
Female genital organs C51-58 144 94.7 0.7 1.2 1.0 2.4
  Cervix uteri C53 10 98.1 1.9 - - -
  Corpus uteri C54 73 98.6 0.3 0.3 0.3 0.5
  Uterus, other C55,C58 1 33.3 - 66.7 - -
  Ovary C56 42 90.6 0.9 2.8 0.9 4.7
  Other female genital C51-52,C57 18 88.8 1.1 - 4.5 5.6
Urinary organs C64-68 63 85.9 1.0 4.2 1.9 7.0
  Kidney C64 37 83.3 - 6.5 2.7 7.5
  Bladder and urinary tract2 C65-68 25 89.8 2.4 0.8 0.8 6.3
Eye C69 1 57.1 - - 14.3 28.6
Brain, central nervous system C70-72,D32-33,D42-43 57 89.5 - 3.5 1.0 5.9
Thyroid gland C73 23 93.8 4.4 0.9 - 0.9
Other endocrine glands C74-75 0 50.0 - - 50.0 -
Illdefined or unknown C76,C80 35 50.3 4.6 13.1 4.6 27.4
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 123 74.0 8.0 0.2 2.1 15.8
  Hodgkin lymphoma C81 9 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 50 96.0 0.4 0.4 0.4 2.8
  Malignant immunoproliferative diseases C88 1 80.0 - - - 20.0
  Myeloma and other plasma cell tumors C90 14 58.0 14.5 - 4.3 23.2
  Leukaemia C91-95 24 50.8 20.5 - 2.5 26.2
  Myelodysplastic syndromes D46 8 28.2 12.8 - - 59.0
  Myeloproliferaitive neoplasms D45,D47 18 64.0 9.0 - 6.7 20.2
Not included above
  Carcinoma in situ of the breast D05 42 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 125 100.0 - - - -
  Borderline tumour of the ovary D39 15 97.3 - - - 2.7
  Basal cell carcinoma of the skin 462 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.